Protein Synthesis in Normal and Regenerating Liver

正常肝脏和再生肝脏中的蛋白质合成

• 批准号: 7527696
• 负责人: DAVID A SHAFRITZ
• 金额: $ 52.34万
• 依托单位: ALBERT EINSTEIN COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 1977
• 资助国家: 美国
• 起止时间: 1977-05-01 至 2012-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7527696
• 关键词: Address; Adult; Age; Aging; Apoptosis; Apoptotic; Attention; Bile Duct Epithelium; Candidate Disease Gene; Cell Death; Cell Line; Cell Proliferation; Cell Transplantation; Cell Transplants; Cells; Characteristics; Chronic; Clinical; Condition; Coupled; Dissection; Drosophila genus; Engraftment; Epithelial; Epithelial Cells; Event; Exhibits; Fetal Liver; Gene Expression; Genes; Genome; Goals; Growth; Hepatic; Hepatic Mass; Hepatocyte; Homologous Gene; Human; Individual; Injury; Lasers; Lead; Liver; Liver Failure; Liver parenchyma; Maintenance; Measures; Methods; Mus; Natural regeneration; Pathway interactions; Phenotype; Process; Progenitor Cell Engraftment; Proliferating; Property; Protein Biosynthesis; Protein Overexpression; Public Health; RNA; Rate; Rattus; Research; Reverse Transcriptase Polymerase Chain Reaction; Role; Signaling Pathway Gene; Site; Staging; Stem cells; System; Therapeutic; Time; Transplantation; Wing; base; bile duct; clinical application; cytokine; density; fetus cell; in vivo; interest; knock-down; laser capture microdissection; liver growth factor; liver transplantation; mutant; research study; self-renewal; size; stem; survivin; uptake

DESCRIPTION (provided by applicant): Currently, whole liver transplantation is the primary method used to treat end stage chronic liver failure. With the marked shortage of available donor livers, there has been considerable interest in identifying stem or progenitor cells can restore liver mass and function. We have demonstrated that fetal liver epithelial cells can repopulate up to 30% of parenchymal mass in normal liver, produce new hepatocytes and bile ducts and continue to proliferate for up to one year after cell transplantation. These are all properties of stem cells and we refer to these cells as fetal liver stem/progenitor cells (FLSPC). We hypothesize that use of a normal liver based cell transplantation system, such as the one we have established, is critical in determining the stem cell potential of isolated cells and cell lines and in identifying essential factors that contribute to their proliferation and differentiation in the liver. Recently, we discovered that fetal liver cells replace host hepatocytes by cell competition, a process originally described in Drosophila. Within this context, experiments are proposed: 1. To study the hypothesis that engraftment of fetal liver stem/progenitor cells into the hepatic parenchyma represents a rate limiting step in liver repopulation. These studies will utilize mouse and rat fetal liver stem/progenitor cells that have been purified to 95% homogeneity using immunomagnetic beads (MACS). 2. To study the hypothesis that modulating cell competition and understanding the circumstances under which this occurs will lead to identifying optimal conditions for liver repopulation by transplanted FLSPC. How long does repopulation/competition continue? Does the age of the host recipient at the time of cell transplantation influence the extent of repopulation? Is competition always driven by increased apoptosis in the host liver? and Can we block liver repopulation by knocking down expression of the anti-apoptotic gene, survivin, in FLSPC prior to their transplantation? 3. To identify specific genes, signaling pathways and mechanisms that regulate cell competition during mammalian liver repopulation. Our hypothesis is that the competitive advantage of transplanted FLSPC over host hepatocytes derives from overexpression of anti-apoptotic genes in these cells, coupled with augmented apoptosis of host hepatocytes through the extrinsic cell death pathway. We will identify the specific genes and signaling pathways involved by isolating RNA from actively proliferating transplanted cell clusters and surrounding host liver by laser-capture micro dissection and studying specific gene expression by RT-PCR, qRT-PCR and high density gene expression microarrays and 4) To directly demonstrate critical stem cell properties of fetal liver epithelial progenitor cells in vivo, including their ability to grow clonally, their bipotency and their capacity for self-renewal. The overall goal of these studies is to find methods to enhance liver repopulation by transplanted hepatic derived cells that will ultimately lead to clinical application in humans. Public Health Relevance: This project is directed toward optimizing repopulation of the adult rat liver with fetal liver stem/progenitor cells and in determining the critical steps, mechanism and genes involved in cell competition, which regulates this process.

描述（申请人提供）：目前，全肝移植是治疗终末期慢性肝衰竭的主要方法。由于供体肝脏的明显短缺，人们对干细胞或祖细胞能否恢复肝脏质量和功能产生了相当大的兴趣。我们已经证明，胎儿肝上皮细胞可以重新填充正常肝脏实质肿块的30%，产生新的肝细胞和胆管，并在细胞移植后持续增殖长达一年。这些都是干细胞的特性，我们把这些细胞称为胎儿肝干细胞/祖细胞（FLSPC）。我们假设使用正常的肝细胞移植系统，例如我们已经建立的系统，对于确定分离细胞和细胞系的干细胞潜力以及确定促进其在肝脏中增殖和分化的基本因素至关重要。最近，我们发现胎儿肝细胞通过细胞竞争取代宿主肝细胞，这一过程最初在果蝇中被描述。在此背景下，提出实验：1。研究胎儿肝干/祖细胞植入肝实质是肝脏再生的限速步骤的假设。这些研究将使用小鼠和大鼠胎肝干细胞/祖细胞，这些细胞使用免疫磁珠（MACS）纯化到95%的同质性。2. 研究调节细胞竞争的假设和理解发生这种情况的情况将导致确定移植FLSPC肝脏再生的最佳条件。繁殖/竞争会持续多久？细胞移植时宿主受体的年龄是否影响细胞再生的程度？竞争是否总是由宿主肝脏细胞凋亡的增加所驱动？我们能否在移植前通过降低FLSPC中抗凋亡基因survivin的表达来阻止肝脏的再生？3. 确定哺乳动物肝脏再生过程中调节细胞竞争的特定基因、信号通路和机制。我们的假设是，移植的FLSPC相对于宿主肝细胞的竞争优势源于这些细胞中抗凋亡基因的过度表达，以及通过外源性细胞死亡途径增强宿主肝细胞的凋亡。我们将通过激光捕获显微解剖从活跃增殖的移植细胞簇和宿主肝脏周围分离RNA，并通过RT-PCR、qRT-PCR和高密度基因表达微阵列研究特异性基因表达，从而确定所涉及的特定基因和信号通路。4)直接证明胎儿肝上皮祖细胞在体内的关键干细胞特性，包括它们的克隆生长能力。它们的潜能和自我更新的能力。这些研究的总体目标是找到通过移植的肝源性细胞来增强肝脏再生的方法，并最终用于人类的临床应用。公共卫生相关性：该项目旨在优化成年大鼠肝脏与胎儿肝干细胞/祖细胞的再生，并确定调节这一过程的细胞竞争的关键步骤、机制和基因。